Heart to Heart Nurses

The mortality rate of cardiogenic shock is around 50%, so prevention and rapid treatment are critical to ensure improved patient outcomes. Guest Amy Shepard, BSN, MS, describes the stages of shock, what leads to cardiogenic shock, treatments, and communication strategies for patients and families.References and Related ResourcesSCAI Shock PyramidPCNA Heart Failure Pocket GuideSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Learn how providing nutrition-based interventions can complement other treatments, address food insecurity, and help reduce patient risks for cardiovascular disease. Guest Bunmi Ogungbe, PhD, MPH, FN, FAHA, FPCNA. describes produce prescriptions, cultural tailoring, cooking skills, and the importance of policies that support access to healthy foods.Related resources: 1115 Demonstration Waiver (CMS): https://www.medicaid.gov/medicaid/section-1115-demonstrationsCE Course: Food is Medicine: https://pcna.net/course/food-is-medicine/PCNA Heart Healthy Toolbox-Healthy Eating: https://pcna.net/resource/healthy-eating-heart-healthy-toolbox/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sharing stories about the work nurses do carries weight with decision-makers. Guest Kristan Langdon, DNP, APRN, ANP-C, CPHQ, emphasizes the importance of communicating your first-hand experiences in compelling conversations at the local, regional, state, and national level.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Utilizing shared decision-making in the diagnosis and management of hypertrophic cardiomyopathy can support positive outcomes for patients, family members and caregivers. Guests Kim Hecker, BSN, BA, RN, and Jillian Thorne, describe the process, and the impacts across all stages of the patient journey. References and related resources:2024 AHA/ACC Guideline for the Management of HCMTwice the Heart Foundation: https://www.instagram.com/twicetheheartfoundation/ PCNA resources on HCM for providers and patientsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Earlier ASCVD risk reduction is better--particularly for patients with diabetes. Guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, discusses the importance of reviewing family history, and shares strategies for decision-making in primary and secondary risk reduction strategies asuch as lowering LDL-C, blood glucose, hypertension, smoking, and other factors.Related Resources: PCNA Lipid resources for providers and patientsPCNA Diabetes resources for providers and patients2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular DiseasePREVENT Risk CalculatorSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the US. Guest James Norton, BSN, RN, shares the hallmark signs and symptoms, and describes how shared decision-making in the care of patients with HCM from diverse populations.Related resources:AHA HCM sudden cardiac death risk calculator: https://professional.heart.org/en/guidelines-and-statements/hcm-risk-calculatorClinical Course & Management of HCM: https://www.nejm.org/doi/full/10.1056/NEJMra1710575HCM Sudden Cardiac Death Calculator: https://professional.heart.org/en/guidelines-and-statements/hcm-risk-calculator2024 AHA/ACC Guideline for the Management of HCM: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001250See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Patients with cardiomyopathy may benefit from virtual patient support groups. Guest Andrea Linder, RN, MSN, CCRC, FPCNA, describes a successful model, with sessions that include both information and opportunities to share their questions and experiences. Andrea also discusses recent clinical trials and the impact of mavacamten on disease management.Related PCNA Resources:Patient Education Tool on Hypertrophic Cardiomyopathy: https://pcna.net/resource/hypertrophic-cardiomyopathy-what-you-need-to-know-fact-sheet/HCP tool on Hypertrophic Cardiomyopathy: https://pcna.net/resource/hypertrophic-cardiomyopathy-what-healthcare-providers-need-to-know/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Afib is on the rise with significant effects on morbidity and mortality. The stagnation of blood in the left atrium and left atrial appendage (LAA) places patients at risk for thromboembolism and stroke. By ligating or closing off the LAA, the risk can be significantly reduced. This intervention offers a valuable alternative to medication, improving safety and quality of life for patients through a minimally invasive, durable stroke prevention strategy. Learn more about the procedure and steps for referring your eligible patient. https://chads2vasccalculator.com/https://www.watchman.com/en-us-hcp/oac-alternative.html?utm_source=oth_site&utm_medium=display-direct&utm_campaign=ic-wm-us-dtr-hcp_app&utm_content=pcna_podcast_oac_alternative-n-n-n&cid=dsp10020937https://www.watchman.com/en-us-hcp/patient-selection-referrals/patient-pre-screening-tool.html?utm_source=oth_site&utm_medium=display-direct&utm_campaign=ic-wm-us-dtr-hcp_app&utm_content=pcna_podcast_patient_screener-n-n-n&cid=dsp10020938https://pcna.net/resource/afib-prepare-for-your-next-visit-discussion-guide/https://pcna.net/resource/the-beat-goes-on-living-with-atrial-fibrillation-online-interactive-patient-guide/https://pcna.net/resource/afib-and-stroke-infographic/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Connection can be the key to health, and those facing disconnection are at significantly higher risk of CVD, stroke, T2D, and other health issues. Guest Lora Peppard, PhD, DNP, PMHNP-BC, describes the importance of relationships and the 6 core beliefs that can help our patients and ourselves have improved health.Resources:Related PCNA CE course: https://pcna.net/course/the-extraordinary-impact-of-connection-on-mental-and-cardiovascular-health/Our Epidemic of Loneliness and Isolation: https://www.hhs.gov/sites/default/files/surgeon-general-social-connection-advisory.pdfhttps://www.julianneholtlunstad.com/ https://bronnieware.com/regrets-of-the-dying/ https://www.zachmercurio.com/https://publichealth.jhu.edu/faculty/3038/christina-d-bethell Family Resilience Connection Index: https://nurtureconnection.org/child-flourishing-a-critical-indicator-for-erh/ American Psychiatric Nurses Association https://www.apna.org/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The bidiretional relationship between cardiac and renal systems means that any dysfunction can cause a cascade of health issues. Learn about team-based care strategies for nurses and other professionals to monitor and manage patients with these conditions from guests Andrew Bzowyckyj, PharmD, BCPS, CDCES, FAPhA, FADCES, and Serina Gbaba, DNP, MBA, FNP-BC.PCNA CKM tools and resources: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/ IPEC core competencies (Interprofessional Education Collaborative): https://www.ipecollaborative.org/ipec-core-competencies CVD in CKD: Pathophysiological Insights and Therapeutic Options: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050686Social Determinants of CVD:https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.319811See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In patients with heart failure, remote hemodynamic monitoring can identify health changes long before symptoms appear, contributing to slower disease progression, improved patient outcomes, and reduced rehospitalizations. Learn more about current and future technology that can support better patient health, and the role of nurses in patient education and monitoring. Guests: Linda Park, PhD, MS, FNP-BC, FAAN, FAHA, FPCNA, and Eryn Bryant, MSN, APRN-CNP, FPCNA.PCNA Heart Failure Tools: https://pcna.net/health-topics/heart-failure/Tele-HF study: https://www.jacc.org/doi/10.1016/j.jchf.2015.07.017 CHAMPION Trial (CMEMs after CRT): Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction https://www.acc.org/latest-in-cardiology/clinical-trials/2015/12/29/12/44/championJournal of American College of Cardiology paper, Remote Monitoring and Heart Failure Scientific Statement: https://www.jacc.org/doi/10.1016/j.jacc.2023.04.010 European Society of Cardiology consensus statement: https://doi.org/10.1093/eurheartjsupp/suae116BMAD trial: BMAD Trial: Wearable Remote Monitor Reduces Hospital Readmission Risk in HF Patients - American College of Cardiology: https://www.acc.org/Latest-in-Cardiology/Articles/2023/03/01/22/45/mon-830am-bmad-acc-2023 GUIDE-HF trial (CMEMS, Lancet): Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial - The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01754-2/abstractESCAPE trial (using RHC / pulm art pressures to guide therapy during ADHF: Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial - PubMed: https://pubmed.ncbi.nlm.nih.gov/16204662/MONITOR-HF trial (improved QOL and functional status w/ CMEMs): Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00923-6/abstract MONITOR-HF: Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial | European Heart Journal | Oxford Academic: https://academic.oup.com/eurheartj/article/45/32/2954/7668040MONITOR-HF (summary in ACC): Remote Hemodynamic Monitoring of Pulmonary Artery Pressures in Patients With Chronic Heart Failure - American College of Cardiology: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/07/18/17/21/monitor-hfHeartLogic: HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.117.004669SCALE-HF-1 Trial (bodyport scale to predict worsening HF trends): Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1 | Circulation: Heart Failure: https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.122.010012See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Dr. Salim Virani as he explores global trends in cardiovascular disease, including shifting risk factors, emerging therapies, and prevention strategies. From disparities in care to the promise of primordial and even pre-primordial prevention, this conversation highlights what nurses and other healthcare professionals can do to improve heart health worldwide.Cleveland Clinic study on risk factors: https://pubmed.ncbi.nlm.nih.gov/35504796/ More information and resources can be found here: https://gcnlf.pcna.net/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.